000278919 001__ 278919
000278919 005__ 20250605100737.0
000278919 0247_ $$2doi$$a10.1038/s41598-025-01352-0
000278919 0247_ $$2pmid$$apmid:40404791
000278919 0247_ $$2pmc$$apmc:PMC12098827
000278919 037__ $$aDZNE-2025-00645
000278919 041__ $$aEnglish
000278919 082__ $$a600
000278919 1001_ $$aBerezhnoy, Georgy$$b0
000278919 245__ $$aApplication of IVDr NMR spectroscopy to stratify Parkinson's disease with absolute quantitation of blood serum metabolites and lipoproteins.
000278919 260__ $$a[London]$$bSpringer Nature$$c2025
000278919 3367_ $$2DRIVER$$aarticle
000278919 3367_ $$2DataCite$$aOutput Types/Journal article
000278919 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1749040345_5050
000278919 3367_ $$2BibTeX$$aARTICLE
000278919 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000278919 3367_ $$00$$2EndNote$$aJournal Article
000278919 520__ $$aThe challenge of early detection and stratification in Parkinson's disease (PD) is urgent due to the current emergence of mechanism-based disease-modifying treatments. In here, metabolomic and lipidomic parameters obtained by a standardized and targeted in vitro diagnostic research (IVDr) platform have a significant potential to address therapy-related questions and generate improved biomarker panels. Our study aimed to use IVDr nuclear magnetic resonance (NMR) spectroscopy to quantify metabolites and lipoproteins in PD blood serum from different cohorts to stratify metabolically driven subtypes of idiopathic and genetic PD. Serum aliquots from three neurodegeneration biobank cohorts (287 samples in total, including 62 PD patient samples with GBA mutation, 98/43 PD patient samples of early/late stages of disease duration, 20 PD samples from patients with mutations in recessive PD genes and some smaller subgroups of mitochondrial and double mutation cases) were prepared and analyzed with IVDr NMR spectroscopy, covering 39 blood serum metabolites and 112 lipoprotein parameters. Uni- and multivariate statistics were used to identify metabolism-driven changes under consideration of typical confounders such as age, sex and disease duration and set into context with clinical biomarkers such as CSF concentrations of alpha-synuclein, neurofilament light chain, and tau protein. Based on the different PD subgroups we performed a total of eight different comparisons. Highlights from these comparisons include increased citrate and dimethylglycine with a decrease of creatinine and methionine in healthy controls and early PD group compared to GBA, PD late and recessive PD. We furthermore identified decreased HDL-3 free cholesterol in genetic PD cases compared to sporadic subject samples (sum of the PD early and PD late groups). Considering medication, we found that the levodopa equivalent daily dose (LEDD) is mostly positively correlated with tyrosine and citrate in sporadic PD compared to pyruvate and phenylalanine in genetic PD. Cerebrospinal fluid levels of alpha-synuclein were negatively correlated with alanine. Further metabolites and lipoproteins with discriminatory power for double mutation PD cases involved ornithine, 2-aminobutyrate and 2-hydroxybutyrate as well as for mitochondrial phenotypes via LDL phospholipid, apolipoprotein and cholesterol subfractions. Quantitative IVDr NMR serum spectroscopy is able to stratify PD patient samples of different etiology and can contribute to a wider understanding of the underlying metabolism-driven alterations e.g. in energy, amino acid, and lipoprotein metabolism. Though our overall cohort was large, major confounders such as age, sex and medication have a strong impact. That is why absolute quantification and detailed patient knowledge about metabolic confounders, is a premise for future translation of NMR serum spectroscopy to routine PD diagnostics.
000278919 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000278919 536__ $$0G:(DE-HGF)POF4-352$$a352 - Disease Mechanisms (POF4-352)$$cPOF4-352$$fPOF IV$$x1
000278919 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000278919 650_7 $$2Other$$aGBA
000278919 650_7 $$2Other$$aBiomarkers
000278919 650_7 $$2Other$$aBlood
000278919 650_7 $$2Other$$aDementia
000278919 650_7 $$2Other$$aParkinson’s disease
000278919 650_7 $$2Other$$aRecessive inheritance
000278919 650_7 $$2NLM Chemicals$$aLipoproteins
000278919 650_7 $$2NLM Chemicals$$aBiomarkers
000278919 650_2 $$2MeSH$$aHumans
000278919 650_2 $$2MeSH$$aParkinson Disease: blood
000278919 650_2 $$2MeSH$$aParkinson Disease: diagnosis
000278919 650_2 $$2MeSH$$aParkinson Disease: genetics
000278919 650_2 $$2MeSH$$aMale
000278919 650_2 $$2MeSH$$aFemale
000278919 650_2 $$2MeSH$$aLipoproteins: blood
000278919 650_2 $$2MeSH$$aMagnetic Resonance Spectroscopy: methods
000278919 650_2 $$2MeSH$$aBiomarkers: blood
000278919 650_2 $$2MeSH$$aMiddle Aged
000278919 650_2 $$2MeSH$$aAged
000278919 650_2 $$2MeSH$$aMetabolomics: methods
000278919 650_2 $$2MeSH$$aMutation
000278919 7001_ $$aBae, Gyuntae$$b1
000278919 7001_ $$aWüst, Leonie$$b2
000278919 7001_ $$0P:(DE-2719)9000366$$aSchulte, Claudia$$b3$$udzne
000278919 7001_ $$aCannet, Claire$$b4
000278919 7001_ $$0P:(DE-2719)2812736$$aWurster, Isabel$$b5$$udzne
000278919 7001_ $$aZimmermann, Milan$$b6
000278919 7001_ $$0P:(DE-2719)9002626$$aJäck, Alexander$$b7$$udzne
000278919 7001_ $$0P:(DE-2719)2812446$$aSpruth, Eike Jakob$$b8
000278919 7001_ $$0P:(DE-2719)9003016$$aHellmann-Regen, Julian$$b9$$udzne
000278919 7001_ $$0P:(DE-2719)2810395$$aRoeske, Sandra$$b10$$udzne
000278919 7001_ $$aPürner, Dominik$$b11
000278919 7001_ $$0P:(DE-2719)2811614$$aGlanz, Wenzel$$b12$$udzne
000278919 7001_ $$0P:(DE-2719)9001334$$aMaass, Fabian$$b13
000278919 7001_ $$0P:(DE-2719)9002827$$aHufschmidt, Felix$$b14$$udzne
000278919 7001_ $$0P:(DE-2719)2810394$$aKilimann, Ingo$$b15$$udzne
000278919 7001_ $$0P:(DE-2719)9001016$$aDinter, Elisabeth$$b16$$udzne
000278919 7001_ $$0P:(DE-2719)9002382$$aKimmich, Okka$$b17$$udzne
000278919 7001_ $$0P:(DE-2719)9001536$$aGamez, Anna$$b18$$udzne
000278919 7001_ $$0P:(DE-2719)2811659$$aLevin, Johannes$$b19$$udzne
000278919 7001_ $$0P:(DE-2719)2811122$$aPriller, Josef$$b20$$udzne
000278919 7001_ $$0P:(DE-2719)2811024$$aPeters, Oliver$$b21$$udzne
000278919 7001_ $$0P:(DE-2719)2000057$$aWagner, Michael$$b22$$udzne
000278919 7001_ $$0P:(DE-2719)9000306$$aStorch, Alexander$$b23$$udzne
000278919 7001_ $$0P:(DE-2719)2812561$$aLingor, Paul$$b24$$udzne
000278919 7001_ $$0P:(DE-2719)2000005$$aDüzel, Emrah$$b25$$udzne
000278919 7001_ $$0P:(DE-2719)9001486$$avan Riesen, Christoph$$b26$$udzne
000278919 7001_ $$0P:(DE-2719)2000056$$aWüllner, Ullrich$$b27$$udzne
000278919 7001_ $$0P:(DE-2719)2000026$$aTeipel, Stefan$$b28$$udzne
000278919 7001_ $$0P:(DE-2719)2814178$$aFalkenburger, Björn$$b29$$udzne
000278919 7001_ $$0P:(DE-2719)2811350$$aBähr, Mathias$$b30$$udzne
000278919 7001_ $$0P:(DE-2719)2000058$$aZerr, Inga$$b31$$udzne
000278919 7001_ $$0P:(DE-2719)2810273$$aPetzold, Gabor C$$b32$$udzne
000278919 7001_ $$0P:(DE-2719)2811324$$aSpottke, Annika$$b33$$udzne
000278919 7001_ $$aRizzu, Patricia$$b34
000278919 7001_ $$0P:(DE-2719)2810593$$aBrosseron, Frederic$$b35$$udzne
000278919 7001_ $$aSchäfer, Hartmut$$b36
000278919 7001_ $$0P:(DE-2719)2320009$$aGasser, Thomas$$b37$$udzne
000278919 7001_ $$aTrautwein, Christoph$$b38
000278919 773__ $$0PERI:(DE-600)2615211-3$$a10.1038/s41598-025-01352-0$$gVol. 15, no. 1, p. 17738$$n1$$p17738$$tScientific reports$$v15$$x2045-2322$$y2025
000278919 8564_ $$uhttps://pub.dzne.de/record/278919/files/DZNE-2025-00645%20SUP.zip
000278919 8564_ $$uhttps://pub.dzne.de/record/278919/files/DZNE-2025-00645.pdf$$yOpenAccess
000278919 8564_ $$uhttps://pub.dzne.de/record/278919/files/DZNE-2025-00645.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000278919 909CO $$ooai:pub.dzne.de:278919$$popenaire$$popen_access$$pVDB$$pdriver$$pdnbdelivery
000278919 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9000366$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b3$$kDZNE
000278919 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2812736$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b5$$kDZNE
000278919 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9002626$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b7$$kDZNE
000278919 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2812446$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b8$$kDZNE
000278919 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9003016$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b9$$kDZNE
000278919 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2810395$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b10$$kDZNE
000278919 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811614$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b12$$kDZNE
000278919 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9002827$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b14$$kDZNE
000278919 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2810394$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b15$$kDZNE
000278919 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9001016$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b16$$kDZNE
000278919 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9002382$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b17$$kDZNE
000278919 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9001536$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b18$$kDZNE
000278919 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811659$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b19$$kDZNE
000278919 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811122$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b20$$kDZNE
000278919 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811024$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b21$$kDZNE
000278919 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2000057$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b22$$kDZNE
000278919 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9000306$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b23$$kDZNE
000278919 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2812561$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b24$$kDZNE
000278919 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2000005$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b25$$kDZNE
000278919 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9001486$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b26$$kDZNE
000278919 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2000056$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b27$$kDZNE
000278919 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2000026$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b28$$kDZNE
000278919 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2814178$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b29$$kDZNE
000278919 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811350$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b30$$kDZNE
000278919 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2000058$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b31$$kDZNE
000278919 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2810273$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b32$$kDZNE
000278919 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811324$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b33$$kDZNE
000278919 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2810593$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b35$$kDZNE
000278919 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2320009$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b37$$kDZNE
000278919 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000278919 9131_ $$0G:(DE-HGF)POF4-352$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vDisease Mechanisms$$x1
000278919 9141_ $$y2025
000278919 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-18
000278919 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-18
000278919 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2024-12-18
000278919 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2024-12-18
000278919 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2024-12-18
000278919 915__ $$0StatID:(DE-HGF)1040$$2StatID$$aDBCoverage$$bZoological Record$$d2024-12-18
000278919 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bSCI REP-UK : 2022$$d2024-12-18
000278919 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2024-07-29T15:28:26Z
000278919 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2024-07-29T15:28:26Z
000278919 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-18
000278919 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2024-12-18
000278919 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-18
000278919 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2024-12-18
000278919 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000278919 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2024-12-18
000278919 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2024-12-18
000278919 915__ $$0StatID:(DE-HGF)1150$$2StatID$$aDBCoverage$$bCurrent Contents - Physical, Chemical and Earth Sciences$$d2024-12-18
000278919 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-18
000278919 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000278919 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-18
000278919 9201_ $$0I:(DE-2719)1210000$$kAG Gasser$$lParkinson Genetics$$x0
000278919 9201_ $$0I:(DE-2719)1111015$$kClinical Research (Munich)$$lClinical Research (Munich)$$x1
000278919 9201_ $$0I:(DE-2719)1811005$$kAG Endres$$lInterdisciplinary Dementia Research$$x2
000278919 9201_ $$0I:(DE-2719)1011201$$kAG Wagner$$lNeuropsychology$$x3
000278919 9201_ $$0I:(DE-2719)5000006$$kAG Düzel$$lClinical Neurophysiology and Memory$$x4
000278919 9201_ $$0I:(DE-2719)1011103$$kAG Spottke$$lClinical Research Platform (CRP)$$x5
000278919 9201_ $$0I:(DE-2719)1011401$$kClinical Research Platform (CRP)$$lClinical Research Platform (CRP)$$x6
000278919 9201_ $$0I:(DE-2719)1510100$$kAG Teipel$$lClinical Dementia Research (Rostock /Greifswald)$$x7
000278919 9201_ $$0I:(DE-2719)1710012$$kAG Falkenburger$$lTranslational Parkinson Research$$x8
000278919 9201_ $$0I:(DE-2719)1011001$$kClinical Research (Bonn)$$lClinical Research Coordination$$x9
000278919 9201_ $$0I:(DE-2719)5000007$$kAG Priller$$lTranslational Neuropsychiatry$$x10
000278919 9201_ $$0I:(DE-2719)5000000$$kAG Peters$$lBiomarker-Assisted Early Detection of Dementias$$x11
000278919 9201_ $$0I:(DE-2719)5000014$$kAG Storch$$lNon-Motor Symptoms in Parkinson's disease$$x12
000278919 9201_ $$0I:(DE-2719)1410002$$kAG Fischer$$lEpigenetics and Systems Medicine in Neurodegenerative Diseases$$x13
000278919 9201_ $$0I:(DE-2719)1011302$$kAG Wüllner$$lBiomarker Parkinson's Disease$$x14
000278919 9201_ $$0I:(DE-2719)1440015$$kClinical Dementia Research (Göttingen)$$lClinical Dementia Research (Göttingen)$$x15
000278919 9201_ $$0I:(DE-2719)1440011-1$$kAG Zerr$$lTranslational Studies and Biomarker$$x16
000278919 9201_ $$0I:(DE-2719)1013020$$kAG Petzold$$lVascular Neurology$$x17
000278919 9201_ $$0I:(DE-2719)1011303$$kAG Heneka$$lNeuroinflammation, Biomarker$$x18
000278919 980__ $$ajournal
000278919 980__ $$aVDB
000278919 980__ $$aUNRESTRICTED
000278919 980__ $$aI:(DE-2719)1210000
000278919 980__ $$aI:(DE-2719)1111015
000278919 980__ $$aI:(DE-2719)1811005
000278919 980__ $$aI:(DE-2719)1011201
000278919 980__ $$aI:(DE-2719)5000006
000278919 980__ $$aI:(DE-2719)1011103
000278919 980__ $$aI:(DE-2719)1011401
000278919 980__ $$aI:(DE-2719)1510100
000278919 980__ $$aI:(DE-2719)1710012
000278919 980__ $$aI:(DE-2719)1011001
000278919 980__ $$aI:(DE-2719)5000007
000278919 980__ $$aI:(DE-2719)5000000
000278919 980__ $$aI:(DE-2719)5000014
000278919 980__ $$aI:(DE-2719)1410002
000278919 980__ $$aI:(DE-2719)1011302
000278919 980__ $$aI:(DE-2719)1440015
000278919 980__ $$aI:(DE-2719)1440011-1
000278919 980__ $$aI:(DE-2719)1013020
000278919 980__ $$aI:(DE-2719)1011303
000278919 9801_ $$aFullTexts